What is NDC 69238-1621?

69238-1621 is the product NDC for metyrosine, Metyrosine 250 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for metyrosine?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

metyrosine NDC 69238-1621 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1621Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1621Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1621-1	6923816210169238162101	100 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-1)Marketed from Jul 24, 2020
69238-1621-3	6923816210369238162103	30 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-3)Marketed from Dec 15, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): metyrosine
Generic name (nonproprietary): metyrosine
Active ingredients: Metyrosine — 250 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Amneal Pharmaceuticals LLCNDC labeler code 69238
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213734
Marketing start: Jul 24, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Catecholamine Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 69238-1621_8dac4742-aa60-4bf5-8c53-46bfce561a3eSPL ID 8dac4742-aa60-4bf5-8c53-46bfce561a3e
Pharmacologic class: Catecholamine Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238162101 followed by a unit qualifier and the quantity

Package 69238-1621-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 69238-1621

What is NDC 69238-1621?: 69238-1621 is the product NDC for metyrosine, Metyrosine 250 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: metyrosine.
What is the active ingredient?: Metyrosine.
Who is the labeler?: Amneal Pharmaceuticals LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for metyrosine?: 2 other product NDCs are listed under this name. See all metyrosine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other metyrosine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Metyrosine	Metyrosine 250 mg/1	CapsuleOral	Dr. Reddy's Laboratories Inc.	75907-166	75907-0166-0175907-0166-30
Metyrosine	Metyrosine 250 mg/1	CapsuleOral	Oceanside Pharmaceuticals	68682-310	68682-0310-01